Timothy Mark Dyer reports 19,095,510 ordinary shares in Addex Therapeutics, representing 8.98% ownership. The position matters to investors because Dyer may be deemed to hold sole voting and dispositive power, while no other person is identified as directing dividends or sale proceeds from those shares.

Key Highlights

  • The ownership percentage is based on 210,292,217 Addex ordinary shares outstanding as of August 26, 2026.
  • Dyer signed the amended ownership report on August 27, 2026, and reported no other Addex share transactions during the relevant 60-day period.
  • Timothy Mark Dyer reports 19,095,510 Addex ordinary shares, representing 8.98% ownership.

Timothy Mark Dyer reports ownership of 19,095,510 ordinary shares in Addex Therapeutics Ltd. (NASDAQ: ADXN), equal to 8.98% of the company. The position places Dyer among Addex’s disclosed significant shareholders under the amended activist ownership report.

Position Includes Ordinary Shares and Options

Addex’s ordinary shares have a nominal value of CHF 0.01 per share. Each American Depositary Share represents 120 ordinary shares. The 8.98% ownership figure is calculated using 210,292,217 ordinary shares outstanding as of August 26, 2026.

Dyer Claims Voting and Dispositive Authority

Dyer may be deemed to possess sole voting and dispositive power over the 19,095,510 shares. The report states that no person other than Dyer has the right to receive dividends, or direct the proceeds of a sale of, those shares. Timothy Mark Dyer signed the amendment on August 27, 2026.